Results 21 to 30 of about 41,661 (291)

Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study [PDF]

, 2023
Background This study aimed to examine the associations between the use of statins concurrent with androgen deprivation therapy (ADT) and the risks of mortality in Asian patients diagnosed with prostate cancer (PCa).
Yan Hiu Athena Lee, Kang Liu, Jeremy Man Ho Hui, Chi Fai Ng, Pias Tang, Kenrick Ng, Jeffrey Shi Kai Chan, Tse, G., Edward Christopher Dee   +8 more
core   +1 more source

A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy [PDF]

, 2012
Background - The severe iatrogenic hypogonadal state induced by medical castration used for treatment of prostate cancer is associated with adverse effects including fatigue, increased fracture risk, and a decrease in skeletal muscle function, which ...
Saxton John M, Nanton Veronica, Helen Crank, Rosario, DJ, Sohanpal, R, Bourke, Liam, John M Saxton, Crank, H., Saxton, John, Bourke Liam, Crank, Helen, Liam Bourke, Saxton, J.M., Nanton, Veronica, Crank Helen, Rosario, D.J., Saxton, John M., Ratna Sohanpal, Sohanpal, Ratna, Saxton, JM, Nanton, V., Bourke, L, Nanton, V, Rosario, Derek J., Sohanpal Ratna, Rosario Derek J, Rosario, D, Derek J Rosario, Veronica Nanton, Crank, H, Bourke, L., Sohanpal, R.   +31 more
core   +1 more source

Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: A population‐based cohort study [PDF]

, 2023
Objective This population-based study examined the association between baseline uric acid (UA) and prostate cancer (PCa)-related mortality amongst PCa patients receiving androgen deprivation therapy (ADT).
Tse, Gary, Ng, Chi Fai, Lee, Y., Chan, J., Dee, E., Ng, Kenrick, Hui, J., Liu, Kang, Liu, T., Leung, Chi Ho   +9 more
core   +1 more source

Bad expression influences time to androgen escape in prostate cancer [PDF]

, 2007
<b>OBJECTIVE</b>: To assess the role of selected downstream Bcl-2 family members (Bad, Bax, Bcl-2 and Bcl-xL) in the development of androgen-independent prostate cancer (AIPC), as androgen-deprivation therapy is the treatment of choice in ...
Teo, K., Traynor, P., Mukherjee, R., Edwards, J., Gemmell, L.   +4 more
core   +1 more source

Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report

Rare Tumors, 2018
Salivary duct carcinoma is a relatively rare salivary cancer, and most cases are androgen receptor -positive. Salivary duct carcinoma growth is suggested to be androgen dependent, which can reportedly be controlled by androgen deprivation therapy ...
Koichiro Wasano, Kouhei Sakurai, Taiji Kawasaki, Kimihide Kusafuka, Masao Kasahara, Naoki Kondo, Ken-ichi Inada, Kaoru Ogawa   +7 more
doaj   +1 more source

Long-term cardiovascular burden in prostate cancer patients receiving androgen deprivation therapy [PDF]

, 2022
Androgen deprivation therapy (ADT), which pharmacologically or surgically suppresses androgen activity, is a key treatment for prostate cancer (PCa).1 However, it is associated with increased cardiovascular risks, including elevated risks of ...
Tse, G.
core  

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

Advances in Urology, 2015
Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods.
Bradley A. Wall, Daniel A. Galvão, Naeem Fatehee, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton   +6 more
doaj   +1 more source

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer. [PDF]

, 2013
BACKGROUND: Standard medical castration reduces muscle mass. We sought to characterize body composition changes in men undergoing maximal androgen suppression with and without exogenous gluocorticoids.
J S de Bono, Pezaro, C., Cassidy, A.M., de Bono, J.S., Pezaro, C, Seed, G., Mukherji, D, de Bono, JS, Omlin, A, Tunariu, N., N Tunariu, G Attard, D Olmos, Attard, G, G Seed, Reid, A.H.M., Seed, G, Mukherji, D., A M Cassidy, Bianchini, D., Cassidy, AM, Olmos, D., A H M Reid, Attard, G., A Omlin, D Bianchini, D Mukherji, Tunariu, N, Olmos, D, Reid, AHM, C Pezaro, Bianchini, D, Omlin, A.   +32 more
core   +1 more source

Outcomes of patients older than 75 years with non-metastatic prostate cancer

Asian Journal of Urology, 2017
Objective: Prostate cancer in elderly patients was formerly treated with androgen deprivation therapy. Since the latter of the 1990s new technologies were introduced into treatments, then strategies have varied.
Yoshiyasu Amiya, Yasutaka Yamada, Masahiro Sugiura, Makoto Sasaki, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu, Shino Murakami, Jun Shimazaki   +8 more
doaj   +1 more source

The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis

PLoS ONE, 2022
Androgen deprivation therapy is a common treatment for prostate cancer. However, this therapy is associated with various adverse effects, such as increased body fat and decreased bone mineral density. Exercise may be useful for ameliorating these adverse
Wenjuan Shao, Hanyue Zhang, Han Qi, Yimin Zhang   +3 more
doaj   +2 more sources